Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982058 · ClinicalTrials.gov registry record · NA
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
A NA study of Prostate Cancer and Sexuality, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 483
- Enrollment target
- 6
- Study locations
NCT01982058: Completed NA study of Prostate Cancer and Sexuality, sponsored by Rutgers, The State University of New Jersey.
NCT01982058 is a NA study of Prostate Cancer and Sexuality that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 483 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (21% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01982058, a NA study of Prostate Cancer and Sexuality, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 483 participants
- Enrollment target
- 6
- Study locations
Study Summary
RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
Primary Outcome
General psychological functioning is assessed by the MHI-38 and the PHQ-9. Cancer-Specific distress is assessed by using the Impact of Events Scale Revised Cancer-Specific concerns is assessed with a 10 item assessment of commonly-experienced problems.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER counseling intervention
- OTHER communication intervention
- OTHER nutrition intervention
Study Locations (6)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
- The University Hospital - Newark
- Garden State Urology - Whippany
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Fox Chase Cancer Center - Philadelphia
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2011-08-18 |
| Est. Completion | 2017-08-07 |
| Phase | NA |
What the finished NCT01982058 record still lists
NCT01982058 is an interventional study that assigns participants to a tested intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (21% lower).
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01982058 lists 6 locations in 3 states (New Jersey, Pennsylvania, New York).
Frequently Asked Questions
What is clinical trial NCT01982058 about?
NCT01982058 is a clinical study titled "Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer". RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their p...
What is the current status of trial NCT01982058?
This trial is currently completed. It is a NA study. The enrollment target is 483 participants. The study started on 2011-08-18. Estimated completion is 2017-08-07.
What conditions does trial NCT01982058 study?
This clinical trial studies the following conditions: Prostate Cancer, Sexuality, Sexual Dysfunction and Infertility.
What interventions are being tested in trial NCT01982058?
The interventions under investigation include: questionnaire administration (OTHER), counseling intervention (OTHER), communication intervention (OTHER), nutrition intervention (OTHER).
Who is sponsoring clinical trial NCT01982058?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01982058 being conducted?
This trial has 6 study locations across New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01982058's enrollment target sits among peer trials
483 116th of 735 higher than 619 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI